U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396168) titled 'Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.' on Feb. 01.
Brief Summary: Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia characterized by progressive, permanent hair loss and scalp symptoms such as pruritus and burning. Current treatments-including topical and intralesional corticosteroids, hydroxychloroquine, and immunosuppressants-are often inadequate, with limited evidence for efficacy and frequent treatment switching or discontinuation due to side effects or lack of response.1,2 Recent systematic reviews and meta-analyses highlight the need for new, targeted therapi...